I took a small position in BLRX earlier this year as a lark. When they halted work on their clinical phase candidate BL-1020 for the treatment of schizophrenia, I got a haircut. Considering their pipeline, I continued to hold my shares thinking that interest would be renewed later down the line. Seems like with the continued positive results from BL-8040 for the treatment of thrombocytopenia (reduced platelet production) related to chemotherapy, maybe finally seeing some activity. Share price has been quietly rising over the past month and volume is up today. Someone accumulating?
They have quite a few other prospects in the pipeline also, check out any of their PRs for details.
Anyone else following this company? Have any thoughts to share? Seems like a steal at the current price.
Quite a few people have been posting asking about other places to go once the Trius circus leaves town.
BLRX is up 11% today and 35% since June 26th. Today they announced a new board member. Some things are definitely happening here- I'm interested in some discussion. Check out BLRX and we can chat on the MB there, see my latest post on BLRX regarding their clinical phase compounds.